Sisomicin sulfate is an aminoglycoside antibiotic primarily used in the treatment of various bacterial infections. It is effective against a wide range of Gram-negative bacteria, such as Pseudomonas aeruginosa and Escherichia coli, and some Gram-positive bacteria. This compound is often utilized in clinical settings to manage serious infections such as septicemia, respiratory tract infections, urinary tract infections, and skin or soft tissue infections. Its application is particularly valuable in cases where other antibiotics may be less effective due to resistance, or in immunocompromised patients. Sisomicin sulfate is administered via injection, ensuring rapid distribution in the body to target and inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby stopping bacterial growth. It is also used in veterinary medicine to treat infections in animals. Careful monitoring is required during its use to minimize potential side effects, such as nephrotoxicity and ototoxicity.